In conclusion, according to the functional similarity of Lp(a) and Fib in pro-atherogenic and anti-fibrinolytic effects, we examined the potential role of combining Lp(a) with Fib for predicting CVE in 8,417 patients with stable CAD and followed up an average of 37.1 months. This evidence concerns the gene FBL and coronary artery disorder.